Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Summary When potent antiretroviral drugs became available in the mid-1990s, a policy of "hit early, hit hard" guided their use: Experts endorsed treatment for all symptomatic HIV-infected patients and ...

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and ...

The intersection of HIV infection and lymphoma has long presented clinical challenges, with HIV-associated lymphomas comprising both AIDS-defining and non-AIDS-defining cancers. Recent advances in ...

Among pregnant women with HIV infection, oral rilpivirine-based antiretroviral regimens were associated with similar rates of adverse pregnancy and birth outcomes as nonrilpivirine regimens. The ...

Assembly Bill 554 would require health plans and insurers to cover all antiretroviral drugs used for PrEP and PEP. Backers say it is a hedge against federal efforts to make HIV-prevention drugs less ...